Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Focal Epilepsy With and Without Secondary Generalization
Interventions
DRUG

Cenobamate

Adult patients affected by epilepsy with focal-onset seizures with or without secondary generalization who have not been adequately controlled despite a history of treatment with 2 or 3 anti-seizure medications.

Trial Locations (1)

Unknown

RECRUITING

Hôpital TARNIER COCHIN, Paris

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY